Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Revenue (2019 - 2025)

Historic Revenue for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to $9.7 million.

  • Beam Therapeutics' Revenue fell 3203.45% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year decrease of 8406.92%. This contributed to the annual value of $63.5 million for FY2024, which is 8318.34% down from last year.
  • Per Beam Therapeutics' latest filing, its Revenue stood at $9.7 million for Q3 2025, which was down 3203.45% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, Beam Therapeutics' Revenue ranged from a high of $316.2 million in Q4 2023 and a low of $6000.0 during Q1 2021
  • For the 5-year period, Beam Therapeutics' Revenue averaged around $30.5 million, with its median value being $14.3 million (2024).
  • Per our database at Business Quant, Beam Therapeutics' Revenue surged by 85105000.0% in 2021 and then tumbled by 9049.09% in 2024.
  • Over the past 5 years, Beam Therapeutics' Revenue (Quarter) stood at $51.1 million in 2021, then tumbled by 60.76% to $20.0 million in 2022, then skyrocketed by 1478.04% to $316.2 million in 2023, then crashed by 90.49% to $30.1 million in 2024, then crashed by 67.75% to $9.7 million in 2025.
  • Its Revenue was $9.7 million in Q3 2025, compared to $8.5 million in Q2 2025 and $7.5 million in Q1 2025.